OP006 Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study
Danese, S, Neurath, M, Kopon, A, Zakko, S, Simmons, T, Fogel, R, Maccarone, J, Zhan, X, Usiskin, K, Chitkara, D
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
P658 Safety and efficacy of MH002, an optimized live biotherapeutic product, for the treatment of mild to moderate ulcerative colitis: a first-in-disease, double-blind, randomized clinical trial
Vermeire, S, Dewint, P, Vansteelant, M, Peterka, M, Štěpek, D, Kierkuś, J, Wiernicka, A, Napora, P, Wolański, Ł, Kopoń, A, Magro, F, Pinheiro, I, Possemiers, S, Haazen, L, Bolca, S
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article
DOP11 Disease clearance after 16 weeks of treatment with vedolizumab in patients with moderate to severe Ulcerative Colitis: An interim analysis from the VERDICT trial
Jairath, V, Zou, G, Adsul, S, Colombel, J F, D’Haens, G R, Freire, M, Moran, G W, Peyrin-Biroulet, L, Sandborn, W J, Sebastian, S, Travis, S, Vermeire, S, Hanžel, J, Ma, C, Sedano, R, Sheridan, P, Arya, N, Beaton, M, Bossuyt, P, Danese, S, Green, D, Harlan III, W, Horynski, M, Kierkus, J, Kopoń, A, Klopocka, M, Petroniene, R, Silverberg, M S, Wolanski, L, Feagan, B G
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article